Cornell University
Library
Cornell UniversityLibrary

eCommons

Help
Log In(current)
  1. Home
  2. Weill Cornell Medicine
  3. Medical College Research and Papers
  4. Department of Psychiatry
  5. Ketamine for comorbid treatment-resistant depression and substance use disorders: balancing risks and opportunities

Ketamine for comorbid treatment-resistant depression and substance use disorders: balancing risks and opportunities

Access Restricted

Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.

During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.

File(s)
41811661.pdf (61.62 KB)
No Access Until
2027-03-11
Permanent Link(s)
https://hdl.handle.net/1813/125167
Collections
Department of Psychiatry
Author
Brody, Benjamin D.
Kanellopoulos, Dora
Journal / Series
Pharmacological reports : PR
Volume & Issue
78(3)
Date Issued
2026-03-11
Publisher
Springer
Keywords
WCM Library Coordinated Deposit
•
Humans
•
Ketamine/therapeutic use/adverse effects
•
Depressive Disorder, Treatment-Resistant/drug therapy/epidemiology
•
Substance-Related Disorders/drug therapy/epidemiology
•
Antidepressive Agents/therapeutic use/adverse effects
•
Comorbidity
•
Electroconvulsive therapy
•
Ketamine
•
Substance use disorders
•
Transcranial magnetic stimulation
•
Treatment-resistant depression
Related DOI
https://doi.org/10.1007/s43440-026-00843-9
Previously Published as
Brody BD, Kanellopoulos D. Ketamine for comorbid treatment-resistant depression and substance use disorders: balancing risks and opportunities. Pharmacological reports : PR. 2026;78(3):625-626. doi: 10.1007/s43440-026-00843-9. PMID: 41811661.
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Rights URI
https://creativecommons.org/licenses/by-nc-nd/4.0/
Type
article

Site Statistics | Help

About eCommons | Policies | Terms of use | Contact Us

copyright © 2002-2026 Cornell University Library | Privacy | Web Accessibility Assistance